drugset / Trial / NCT00156247

Acitretin and Etanercept in Psoriasis

NCT00156247

NaSingle-groupOpen-labelTreatment

Summary

To determine whether acitretin plus etanercept is more effective than etanercept alone in clearing psoriasis plaques in adults.

Timeline

Start
2005-09
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Acitretin Small molecule 25 mg Oral

Indications